These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

381 related items for PubMed ID: 23794090

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Therapeutic inhibition of fatty acid oxidation in right ventricular hypertrophy: exploiting Randle's cycle.
    Fang YH, Piao L, Hong Z, Toth PT, Marsboom G, Bache-Wiig P, Rehman J, Archer SL.
    J Mol Med (Berl); 2012 Jan; 90(1):31-43. PubMed ID: 21874543
    [Abstract] [Full Text] [Related]

  • 5. GRK2-mediated inhibition of adrenergic and dopaminergic signaling in right ventricular hypertrophy: therapeutic implications in pulmonary hypertension.
    Piao L, Fang YH, Parikh KS, Ryan JJ, D'Souza KM, Theccanat T, Toth PT, Pogoriler J, Paul J, Blaxall BC, Akhter SA, Archer SL.
    Circulation; 2012 Dec 11; 126(24):2859-69. PubMed ID: 23124027
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Pulmonary artery banding is a relevant model to study the right ventricular remodeling and dysfunction that occurs in pulmonary arterial hypertension.
    Akazawa Y, Okumura K, Ishii R, Slorach C, Hui W, Ide H, Honjo O, Sun M, Kabir G, Connelly K, Friedberg MK.
    J Appl Physiol (1985); 2020 Aug 01; 129(2):238-246. PubMed ID: 32644912
    [Abstract] [Full Text] [Related]

  • 10. Loss of KCNK3 is a hallmark of RV hypertrophy/dysfunction associated with pulmonary hypertension.
    Lambert M, Boet A, Rucker-Martin C, Mendes-Ferreira P, Capuano V, Hatem S, Adão R, Brás-Silva C, Hautefort A, Michel JB, Dorfmuller P, Fadel E, Kotsimbos T, Price L, Jourdon P, Montani D, Humbert M, Perros F, Antigny F.
    Cardiovasc Res; 2018 May 01; 114(6):880-893. PubMed ID: 29360952
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Inflammatory Glycoprotein 130 Signaling Links Changes in Microtubules and Junctophilin-2 to Altered Mitochondrial Metabolism and Right Ventricular Contractility.
    Prisco SZ, Hartweck LM, Rose L, Lima PDA, Thenappan T, Archer SL, Prins KW.
    Circ Heart Fail; 2022 Jan 01; 15(1):e008574. PubMed ID: 34923829
    [Abstract] [Full Text] [Related]

  • 13. Allogenic stem cell therapy improves right ventricular function by improving lung pathology in rats with pulmonary hypertension.
    Umar S, de Visser YP, Steendijk P, Schutte CI, Laghmani el H, Wagenaar GT, Bax WH, Mantikou E, Pijnappels DA, Atsma DE, Schalij MJ, van der Wall EE, van der Laarse A.
    Am J Physiol Heart Circ Physiol; 2009 Nov 01; 297(5):H1606-16. PubMed ID: 19783775
    [Abstract] [Full Text] [Related]

  • 14. Metabolism and bioenergetics in the right ventricle and pulmonary vasculature in pulmonary hypertension.
    Archer SL, Fang YH, Ryan JJ, Piao L.
    Pulm Circ; 2013 Jan 01; 3(1):144-52. PubMed ID: 23662191
    [Abstract] [Full Text] [Related]

  • 15. Macrophage-NLRP3 Activation Promotes Right Ventricle Failure in Pulmonary Arterial Hypertension.
    Al-Qazazi R, Lima PDA, Prisco SZ, Potus F, Dasgupta A, Chen KH, Tian L, Bentley RET, Mewburn J, Martin AY, Wu D, Jones O, Maurice DH, Bonnet S, Provencher S, Prins KW, Archer SL.
    Am J Respir Crit Care Med; 2022 Sep 01; 206(5):608-624. PubMed ID: 35699679
    [Abstract] [Full Text] [Related]

  • 16. Does Cell-Type-Specific Silencing of Monoamine Oxidase B Interfere with the Development of Right Ventricle (RV) Hypertrophy or Right Ventricle Failure in Pulmonary Hypertension?
    Brosinsky P, Heger J, Sydykov A, Weiss A, Klatt S, Czech L, Kraut S, Schermuly RT, Schlüter KD, Schulz R.
    Int J Mol Sci; 2024 Jun 05; 25(11):. PubMed ID: 38892401
    [Abstract] [Full Text] [Related]

  • 17. Effect of p53 activation on experimental right ventricular hypertrophy.
    Veeroju S, Mamazhakypov A, Rai N, Kojonazarov B, Nadeau V, Breuils-Bonnet S, Li L, Weissmann N, Rohrbach S, Provencher S, Bonnet S, Seeger W, Schermuly R, Novoyatleva T.
    PLoS One; 2020 Jun 05; 15(6):e0234872. PubMed ID: 32559203
    [Abstract] [Full Text] [Related]

  • 18. Neuregulin-1 improves right ventricular function and attenuates experimental pulmonary arterial hypertension.
    Mendes-Ferreira P, Maia-Rocha C, Adão R, Mendes MJ, Santos-Ribeiro D, Alves BS, Cerqueira RJ, Castro-Chaves P, Lourenço AP, De Keulenaer GW, Leite-Moreira AF, Brás-Silva C.
    Cardiovasc Res; 2016 Jan 01; 109(1):44-54. PubMed ID: 26503987
    [Abstract] [Full Text] [Related]

  • 19. Novel assessment of haemodynamic kinetics with acute exercise in a rat model of pulmonary arterial hypertension.
    Brown MB, Chingombe TJ, Zinn AB, Reddy JG, Novack RA, Cooney SA, Fisher AJ, Presson RG, Lahm T, Petrache I.
    Exp Physiol; 2015 Jun 01; 100(6):742-54. PubMed ID: 25867528
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.